Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06948877 · ClinicalTrials.gov registry record · NA
"Up-Armoring" At-Risk Military Couples: A Stepped Approach to Early Intervention and Strengthening of Military Families
A NA study, sponsored by Wright State University.
- Completed
- Registry status
- NA
- Development phase
- 581
- Enrollment target
NCT06948877: Completed NA study, sponsored by Wright State University.
NCT06948877 is a NA study that has completed, run by Wright State University. The registered enrollment target is 581 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06948877, a NA study, has completed, sponsored by Wright State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 581 participants
- Enrollment target
Study Summary
The study tested whether giving young, partnered military service members access to an online relationship help website would help prevent future relationship problems compared to partnered service member who did not have access to the website
Primary Outcome
The MSI-B is a true-false, self-report measure of relationship distress derived from the full The MSI-B is a true-false, self-report measure of relationship distress derived from the full True-false, self-report measure of relationship distress
Interventions
- BEHAVIORAL ARMOR Online
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 581 participants |
| Start Date | 2021-10-19 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT06948877 record still lists
NCT06948877 is an interventional study that assigns participants to a tested intervention. The registered 581 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which ARMOR Online is the first listed.
NCT06948877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06948877 about?
NCT06948877 is a clinical study titled ""Up-Armoring" At-Risk Military Couples: A Stepped Approach to Early Intervention and Strengthening of Military Families". The study tested whether giving young, partnered military service members access to an online relationship help website would help prevent future relationship problems compared to partnered service member who did not have access to the website
What is the current status of trial NCT06948877?
This trial is currently completed. It is a NA study. The enrollment target is 581 participants. The study started on 2021-10-19. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT06948877?
The interventions under investigation include: ARMOR Online (BEHAVIORAL).
Who is sponsoring clinical trial NCT06948877?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06948877's enrollment target sits among peer trials
581 177th of 2000 higher than 1,824 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06350097 · 582 participants · Phase 3
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- NCT06563895 · 582 participants · Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- NCT06819007 · 582 participants · Phase 3
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI